[1] |
World Health Organization. Global tuberculosis report 2018[S]. Geneva:WHO, 2018.
|
[2] |
陈红梅, 国杰, 胡凤梅. 西藏20年结核病治疗转归情况分析[J]. 西藏医药, 2015, 36(3):5-8.
|
[3] |
孙蕊, 王志锐, 穆成, 等. Xpert Mtb/RIF、痰涂片和培养在疑似肺结核诊断中的对比研究[J]. 中国卫生检验杂志, 2018, 28(1):10-12.
|
[4] |
DIERBERG K L, DORJEE K, SALVO F, et al. Improved detection of tuberculosis and multidrug-resistant tuberculosis among Tibetan refugees,India[J]. Emerg Infect Dis, 2016, 22(3):463-468.
DOI
URL
|
[5] |
李波, 吴进凤, 欧喜超, 等. Xpert MTB/RIF、荧光染色镜检、改良罗氏培养在肺结核实验室诊断中的应用[J]. 临床肺科杂志, 2018, 23(7):1165-1168.
|
[6] |
赵雁林, 逄宇. 结核病实验室检验规程[M]. 北京: 人民卫生出版社, 2015.
|
[7] |
NESHATI H, SHEYBANI F, NADERI H, et al. Diagnostic errors in tuberculous patients:a multicenter study from a developing country[J]. J Environ Public Health, 2018, 2018:1975931.
|
[8] |
付沛文, 李世宝, 李洪春, 等. Xpert MTB/RIF试验快速诊断结核病的研究进展[J]. 中国感染控制杂志, 2017, 16(8):779-783.
|
[9] |
嘎松卓嘎, 普芝, 巴桑琼达, 等. Gene-Xpert MTB/RIF在西藏地区结核病诊断中的应用研究[J]. 中国实用医药, 2017, 12(26):27-28.
|
[10] |
ZHANG M, TANG X, WANG Y, et al. Variants of TLR1 associated with tuberculosis susceptibility in the Chinese Tibetan population but not in Han Chinese[J]. Infect Genet Evol, 2018, 61:53-59.
DOI
URL
|
[11] |
HE S, WANG B, ZHU X, et al. Association of IFNGR1 and IFNG genetic polymorphisms with the risk for pulmonary tuberculosis in the Chinese Tibetan population[J]. Oncotarget, 2017, 8(58):98417-98425.
DOI
URL
|
[12] |
TIAN P W, WANG Y, SHEN Y C, et al. Different risk factors of recurrent pulmonary tuberculosis between Tibetan and Han populations in Southwest China[J]. Eur Rev Med Pharmacol Sci, 2014, 18(10):1482-1486.
|
[13] |
SALVO F, DORJEE K, DIERBERG K, et al. Survey of tuberculosis drug resistance among Tibetan refugees in India[J]. Int J Tuberc Lung Dis, 2014, 18(6):655-662.
DOI
URL
|